trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['daisy', 'tdxd', 't-dxd', 'biomarker', 'marker ']
the #oncoalerttoptweet #esmo22 day 3 #daisy
biomarker analysis on t-dxd mechanisms of resistance 1 spatial transcriptomic response to t-dxd different according to her2 expression
2 erbb2 hemizygous deletion assoc w/upfront tdxd resistance 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??